Purnawan Pontana Putra
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Purnawan Pontana Putra has a total of 60 co-authors. Here are the top co-authors by number of shared publications:
- Aiyi Asnawi
Department of Pharmacochemistry, Faculty of Pharmacy, Universitas Bhakti Kencana, Jl. Soekarno-Hatta No. 754, Bandung 40617, Indonesia
3 shared publications - Aliyah Aliyah
Faculty of Pharmacy, Hasanuddin University, Makassar, Indonesia
2 shared publications - Andi Dian Permana
Hasanuddin University
2 shared publications - Cindy Kristina Enggi
Faculty of Pharmacy, Hasanuddin University, Makassar, Indonesia
2 shared publications - Frederika Tangdilintin
Faculty of Pharmacy, Hasanuddin University, Makassar, Indonesia
2 shared publications - Habiburrahim Burhanuddin
Faculty of Pharmacy, Hasanuddin University, Makassar, Indonesia
2 shared publications
Latest Publications
- Open Access
- 12 January 2026
- Published by Universitas Mataram in Jurnal Ilmiah Profesi Pendidikan
- Vol. 11 (1) , 960-965
Pengaruh Penggunaan Video Pembelajaran terhadap Pengetahuan Mahasiswa tentang Pengemasan Pangan
Pemahaman mengenai pengemasan pangan merupakan kompetensi penting bagi mahasiswa pendidikan vokasi bidang tata boga, namun banyak mahasiswa yang masih mengalami kesulitan dalam mengaitkan konsep teoretis dengan penerapannya dalam praktik. Penelitian ini bertujuan untuk mengkaji pengaruh penggunaan video pembelajaran terhadap pengetahuan mahasiswa tentang pengemasan pangan pada mata kuliah Pengawetan Pangan. Penelitian menggunakan desain one-group pretest–posttest dengan melibatkan 29 mahasiswa Program Studi D3 Tata Boga Universitas Negeri Padang. Mahasiswa diberikan tes pilihan ganda sebelum dan sesudah menonton video pembelajaran yang dikembangkan dalam penelitian ini. Hasil penelitian menunjukkan adanya peningkatan pengetahuan mahasiswa yang signifikan, dengan nilai rata-rata meningkat dari 76,21 pada pretest menjadi 93,45 pada posttest (p < 0,05). Temuan ini menunjukkan bahwa video pembelajaran membantu memperjelas konsep pengemasan melalui penjelasan visual dan contoh-contoh aplikatif. Penelitian ini menyimpulkan bahwa pembelajaran berbasis video dapat digunakan sebagai strategi pembelajaran pendukung dalam pendidikan vokasi, khususnya untuk memperkuat pemahaman mahasiswa mengenai keamanan pangan dan praktik pengemasan yang bertanggung jawab.
- 12 January 2026
- Published by Universitas Mataram in Jurnal Ilmiah Profesi Pendidikan
- Vol. 11 (1) , 960-965
Open AccessPengaruh Penggunaan Video Pembelajaran terhadap Pengetahuan Mahasiswa tentang Pengemasan Pangan
Pemahaman mengenai pengemasan pangan merupakan kompetensi penting bagi mahasiswa pendidikan vokasi bidang tata boga, namun banyak mahasiswa yang masih mengalami kesulitan dalam mengaitkan konsep teoretis dengan penerapannya dalam praktik. Penelitian ini bertujuan untuk mengkaji pengaruh penggunaan video pembelajaran terhadap pengetahuan mahasiswa tentang pengemasan pangan pada mata kuliah Pengawetan Pangan. Penelitian menggunakan desain one-group pretest–posttest dengan melibatkan 29 mahasiswa Program Studi D3 Tata Boga Universitas Negeri Padang. Mahasiswa diberikan tes pilihan ganda sebelum dan sesudah menonton video pembelajaran yang dikembangkan dalam penelitian ini. Hasil penelitian menunjukkan adanya peningkatan pengetahuan mahasiswa yang signifikan, dengan nilai rata-rata meningkat dari 76,21 pada pretest menjadi 93,45 pada posttest (p < 0,05). Temuan ini menunjukkan bahwa video pembelajaran membantu memperjelas konsep pengemasan melalui penjelasan visual dan contoh-contoh aplikatif. Penelitian ini menyimpulkan bahwa pembelajaran berbasis video dapat digunakan sebagai strategi pembelajaran pendukung dalam pendidikan vokasi, khususnya untuk memperkuat pemahaman mahasiswa mengenai keamanan pangan dan praktik pengemasan yang bertanggung jawab.
- Open Access
- 24 October 2025
- Published by JCFCorp SG PTE LTD in Pharmacy Practice
- Vol. 23 (3) , 1-9
Long-Term Impact of Pillbox Use on Medication Adherence in Patients with Type 2 Diabetes Mellitus
Background: This follow-up study assessed the long-term impact of pillbox use on medication adherence in type 2 diabetes mellitus (T2DM) patients over two years. Method: A cross-sectional study consisting of 52 participants was divided into two groups: pillbox (intervention) and non-pillbox (control). Adherence was measured using the pill count method, and clinical outcomes such as blood glucose levels were recorded. Results: Results revealed that the pillbox group had significantly higher adherence rates over time, with adherence increasing from 94.01% initially to 96.67% after two years. In contrast, adherence in the non-pillbox group declined from 88.62% to 88.26%. Postprandial blood glucose control improved significantly in the pillbox group (141.38 mg/dl to 129.88 mg/dl), whereas the non-pillbox group experienced an increase (137.96 mg/dl to 145.69 mg/dl). Fasting and random blood glucose levels did not show statistically significant changes. The analysis identified education and occupation as important predictors of adherence, while factors such as age, gender, comorbidities, and medication changes showed marginal or non-significant effects. Conclusion: These findings suggest that pillbox interventions can effectively improve long-term medication adherence and postprandial blood glucose control in T2DM patients, particularly when considering sociodemographic factors like education and occupation. Further research should explore the broader implications of these findings for diabetes management and potential strategies to improve adherence in diverse patient populations.
- 24 October 2025
- Published by JCFCorp SG PTE LTD in Pharmacy Practice
- Vol. 23 (3) , 1-9
Open AccessLong-Term Impact of Pillbox Use on Medication Adherence in Patients with Type 2 Diabetes Mellitus
Background: This follow-up study assessed the long-term impact of pillbox use on medication adherence in type 2 diabetes mellitus (T2DM) patients over two years. Method: A cross-sectional study consisting of 52 participants was divided into two groups: pillbox (intervention) and non-pillbox (control). Adherence was measured using the pill count method, and clinical outcomes such as blood glucose levels were recorded. Results: Results revealed that the pillbox group had significantly higher adherence rates over time, with adherence increasing from 94.01% initially to 96.67% after two years. In contrast, adherence in the non-pillbox group declined from 88.62% to 88.26%. Postprandial blood glucose control improved significantly in the pillbox group (141.38 mg/dl to 129.88 mg/dl), whereas the non-pillbox group experienced an increase (137.96 mg/dl to 145.69 mg/dl). Fasting and random blood glucose levels did not show statistically significant changes. The analysis identified education and occupation as important predictors of adherence, while factors such as age, gender, comorbidities, and medication changes showed marginal or non-significant effects. Conclusion: These findings suggest that pillbox interventions can effectively improve long-term medication adherence and postprandial blood glucose control in T2DM patients, particularly when considering sociodemographic factors like education and occupation. Further research should explore the broader implications of these findings for diabetes management and potential strategies to improve adherence in diverse patient populations.
- Open Access
- 1 October 2025
- Published by Maad Rayan Publishing Company in Journal of Herbmed Pharmacology
- Vol. 14 (4) , 514-523
Exploring marine natural compounds: In silico investigation of Halimeda tuna natural compounds for PPAR-γ targeting in type 2 diabetes
Introduction: The peroxisome proliferator-activated receptor gamma (PPAR-γ) is a crucial regulator of glucose metabolism and insulin sensitivity, making it a primary target for diabetes therapy. Halimeda tuna, a marine alga, has shown potential as a source of bioactive chemicals with possible anti-diabetic effects. However, there is little information on the particular interactions of H. tuna-derived natural compounds with PPAR-γ. This research aimed to find prospective lead compounds by molecular docking and to evaluate their stability and interaction dynamics with the PPAR-γ using molecular dynamics simulations. Methods: The natural compounds were downloaded from http://knapsack3d.sakura.ne.jp/, then refined based on Lipinski’s criteria, and optimized for molecular docking. The PPAR-γ macromolecule (PDB ID 1I7I) was also refined to retain only the receptor and its native natural compound (AZ2). Molecular docking was carried out using AutoDock 4.2 to analyze the binding energy and binding mode. To evaluate the stability of the natural compound-receptor complexes, molecular dynamics simulations were conducted for 100 ns using Gromacs 2023. Results: The molecular docking studies showed that the binding energies for M12 and M7 were -10.77 kcal/mol and -9.91 kcal/mol, respectively. However, when molecular dynamics (MD) simulations were conducted, the total energy values became more negative, with M12 showing -48.25 kcal/mol and M7 -40.13 kcal/mol. Conclusion: M12 (2-desoxypleniradin-L-|A-arabinopyranoside, 2-acetate) appears to be a promising candidate as a potential PPAR-γ inhibitor for treating type 2 diabetes.
- 1 October 2025
- Published by Maad Rayan Publishing Company in Journal of Herbmed Pharmacology
- Vol. 14 (4) , 514-523
Open AccessExploring marine natural compounds: In silico investigation of Halimeda tuna natural compounds for PPAR-γ targeting in type 2 diabetes
Introduction: The peroxisome proliferator-activated receptor gamma (PPAR-γ) is a crucial regulator of glucose metabolism and insulin sensitivity, making it a primary target for diabetes therapy. Halimeda tuna, a marine alga, has shown potential as a source of bioactive chemicals with possible anti-diabetic effects. However, there is little information on the particular interactions of H. tuna-derived natural compounds with PPAR-γ. This research aimed to find prospective lead compounds by molecular docking and to evaluate their stability and interaction dynamics with the PPAR-γ using molecular dynamics simulations. Methods: The natural compounds were downloaded from http://knapsack3d.sakura.ne.jp/, then refined based on Lipinski’s criteria, and optimized for molecular docking. The PPAR-γ macromolecule (PDB ID 1I7I) was also refined to retain only the receptor and its native natural compound (AZ2). Molecular docking was carried out using AutoDock 4.2 to analyze the binding energy and binding mode. To evaluate the stability of the natural compound-receptor complexes, molecular dynamics simulations were conducted for 100 ns using Gromacs 2023. Results: The molecular docking studies showed that the binding energies for M12 and M7 were -10.77 kcal/mol and -9.91 kcal/mol, respectively. However, when molecular dynamics (MD) simulations were conducted, the total energy values became more negative, with M12 showing -48.25 kcal/mol and M7 -40.13 kcal/mol. Conclusion: M12 (2-desoxypleniradin-L-|A-arabinopyranoside, 2-acetate) appears to be a promising candidate as a potential PPAR-γ inhibitor for treating type 2 diabetes.
- 1 July 2025
- Published by A and V Publications in Research Journal of Pharmacy and Technology
- Vol. 18 (7) , 3212-3220
In Silico Analysis of α-Mangostin Derivatives: Investigating Their Interaction with B-cell Lymphoma 2 (Bcl-2) Receptor
α-Mangostin emerges as a highly potent chemopreventive and chemotherapeutic agent, demonstrating significant efficacy in suppressing carcinogenesis at various stages, including cell division, proliferation, apoptosis, inflammation, and metastasis. Furthermore, derivatives of α-Mangostin exhibit potential in addressing cancer-related ailments. This study aimed to investigate the binding interactions and dynamic behavior of α-Mangostin derivatives with the B-cell lymphoma 2 receptor (Bcl-2) through a comprehensive computational approach that combined molecular docking, molecular dynamics simulation, and ADMET prediction. The physicochemical and pharmacokinetic properties of α-Mangostin and its derivatives were predicted using the SWISS-ADME tool and the pkCSM web service, employing SMILES data as input. For molecular docking, the three-dimensional structure of Bcl-2 was utilized, and docking simulations were conducted using the Gnina software to explore the affinity and interaction of the derivatives with Bcl-2. Among the derivatives, derivative 6 displayed the most promising docking results, with a binding energy of -7.95 kcal/mol and significant π-Sigma interaction at the active site on the Tyr161 amino acid residue. Additionally, interactions such as conventional hydrogen bonds, carbon hydrogen bonds, π-cation, and alkyl were observed. To assess the stability and dynamic behavior of derivative 6 in the Bcl-2 complex, a 100-nanosecond molecular dynamics (MD) simulation was performed using GROMACS software. The results suggest that derivative 6 derived from α-Mangostin holds potential for oral drug development, highlighting its promise for future therapeutic applications based free energy calculation using molecular mechanics generalized born surface area (MM-GBSA).
- 1 July 2025
- Published by A and V Publications in Research Journal of Pharmacy and Technology
- Vol. 18 (7) , 3212-3220
In Silico Analysis of α-Mangostin Derivatives: Investigating Their Interaction with B-cell Lymphoma 2 (Bcl-2) Receptor
α-Mangostin emerges as a highly potent chemopreventive and chemotherapeutic agent, demonstrating significant efficacy in suppressing carcinogenesis at various stages, including cell division, proliferation, apoptosis, inflammation, and metastasis. Furthermore, derivatives of α-Mangostin exhibit potential in addressing cancer-related ailments. This study aimed to investigate the binding interactions and dynamic behavior of α-Mangostin derivatives with the B-cell lymphoma 2 receptor (Bcl-2) through a comprehensive computational approach that combined molecular docking, molecular dynamics simulation, and ADMET prediction. The physicochemical and pharmacokinetic properties of α-Mangostin and its derivatives were predicted using the SWISS-ADME tool and the pkCSM web service, employing SMILES data as input. For molecular docking, the three-dimensional structure of Bcl-2 was utilized, and docking simulations were conducted using the Gnina software to explore the affinity and interaction of the derivatives with Bcl-2. Among the derivatives, derivative 6 displayed the most promising docking results, with a binding energy of -7.95 kcal/mol and significant π-Sigma interaction at the active site on the Tyr161 amino acid residue. Additionally, interactions such as conventional hydrogen bonds, carbon hydrogen bonds, π-cation, and alkyl were observed. To assess the stability and dynamic behavior of derivative 6 in the Bcl-2 complex, a 100-nanosecond molecular dynamics (MD) simulation was performed using GROMACS software. The results suggest that derivative 6 derived from α-Mangostin holds potential for oral drug development, highlighting its promise for future therapeutic applications based free energy calculation using molecular mechanics generalized born surface area (MM-GBSA).
- Open Access
- 26 February 2025
- Published by Springer Nature in DARU Journal of Pharmaceutical Sciences
- Vol. 33 (1) , 1
Correction: Development of amphotericin B inclusion complex formulation in dissolvable microarray patches for intravaginal delivery
- 26 February 2025
- Published by Springer Nature in DARU Journal of Pharmaceutical Sciences
- Vol. 33 (1) , 1
Open AccessCorrection: Development of amphotericin B inclusion complex formulation in dissolvable microarray patches for intravaginal delivery
- Open Access
- 24 February 2025
- Published by Innovare Academic Sciences Pvt Ltd in International Journal of Applied Pharmaceutics
- p. 51-60
COMPUTATIONAL STUDY OF COMPOUNDS IN MANGOSTEEN (GARCINIA MANGOSTANA L.) AS A CANDIDATE OF LUNG CANCER THERAPY
Objective: Cancer involves uncontrolled cell growth and spreading to other body parts. Lung cancer is the most common and deadliest cancer worldwide, with treatments often causing significant side effects. This research aims to predict the potential of compounds in mangosteen (Garcinia mangostana L.) as a candidate for lung cancer therapy. Methods: The methods used in this research are network pharmacology analysis using string and cytoscape, molecular docking using deep learning, and molecular dynamics simulations. Results: Eleven compounds have been identified in Garcinia mangostana L., including catechin, gartanin, alpha-mangostin, norathyriol, maclurin, 8-deoxygartanin, beta-mangostin, gamma-mangostin, garcinone A, garcinone B, and garcinone D. Based on ADMET analysis, these compounds exhibit varying degrees of absorption, distribution, metabolism, excretion, and toxicity profiles, which can provide valuable insights into their potential therapeutic applications and safety profiles. It has significant protein targets identified are AURKA, PLK1, CCNA2, and KIF11, with AURKA chosen for molecular docking and molecular dynamics simulations. Molecular docking revealed garcinone D has a binding energy-10.30 kcal/mol and gamma-Mangostin-10.28 kcal/mol had better affinity than the native ligand adenosine-5'-diphosphate-9.00 kcal/mol. Molecular dynamics simulations indicated that garcinone D and gamma-Mangostin were less stable than the native ligand over a 100 ns simulation. Conclusion: The compounds, including gamma-Mangostin and garcinone D, target the lung cancer-related protein AURKA and are demonstrate to affect key biological pathways such as the cell cycle and motor proteins. Deep learning docking shows that garcinone D and gamma-mangostin exhibit high affinity, while molecular dynamics simulations confirm their stability over 100 ns.
- 24 February 2025
- Published by Innovare Academic Sciences Pvt Ltd in International Journal of Applied Pharmaceutics
- p. 51-60
Open AccessCOMPUTATIONAL STUDY OF COMPOUNDS IN MANGOSTEEN (GARCINIA MANGOSTANA L.) AS A CANDIDATE OF LUNG CANCER THERAPY
Objective: Cancer involves uncontrolled cell growth and spreading to other body parts. Lung cancer is the most common and deadliest cancer worldwide, with treatments often causing significant side effects. This research aims to predict the potential of compounds in mangosteen (Garcinia mangostana L.) as a candidate for lung cancer therapy. Methods: The methods used in this research are network pharmacology analysis using string and cytoscape, molecular docking using deep learning, and molecular dynamics simulations. Results: Eleven compounds have been identified in Garcinia mangostana L., including catechin, gartanin, alpha-mangostin, norathyriol, maclurin, 8-deoxygartanin, beta-mangostin, gamma-mangostin, garcinone A, garcinone B, and garcinone D. Based on ADMET analysis, these compounds exhibit varying degrees of absorption, distribution, metabolism, excretion, and toxicity profiles, which can provide valuable insights into their potential therapeutic applications and safety profiles. It has significant protein targets identified are AURKA, PLK1, CCNA2, and KIF11, with AURKA chosen for molecular docking and molecular dynamics simulations. Molecular docking revealed garcinone D has a binding energy-10.30 kcal/mol and gamma-Mangostin-10.28 kcal/mol had better affinity than the native ligand adenosine-5'-diphosphate-9.00 kcal/mol. Molecular dynamics simulations indicated that garcinone D and gamma-Mangostin were less stable than the native ligand over a 100 ns simulation. Conclusion: The compounds, including gamma-Mangostin and garcinone D, target the lung cancer-related protein AURKA and are demonstrate to affect key biological pathways such as the cell cycle and motor proteins. Deep learning docking shows that garcinone D and gamma-mangostin exhibit high affinity, while molecular dynamics simulations confirm their stability over 100 ns.
- 8 February 2025
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 343, 119380
A new xanthone from Garcinia cowa Roxb. and its anti-inflammatory activity
- 8 February 2025
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 343, 119380
A new xanthone from Garcinia cowa Roxb. and its anti-inflammatory activity
- 12 December 2024
- Published by Springer Nature in DARU Journal of Pharmaceutical Sciences
- Vol. 33 (1) , 1-19
Development of amphotericin B inclusion complex formulation in dissolvable microarray patches for intravaginal delivery
Background Amphotericin B (AMB) is a drug used to treat vulvovaginal candidiasis (VVC), which is a fungal infection affecting the vagina and vulva. Nevertheless, the substance's limited capacity to dissolve in water leads to poor absorption when taken orally, hence diminishing its therapeutic efficacy. In order to address this limitation, β-cyclodextrin (βCD) was used to create AMB in the form of an inclusion complex. Objective This study aims to enhance the solubility and bioavailability of AMB by formulating it into an inclusion complex with βCD. Subsequently, we developed dissolvable microarray patches (DMP) as a novel drug delivery system, optimizing the formulation for improved retention, penetration, and controlled release of AMB. Methods The stability of the AMB-βCD inclusion complx (IC) structure has been confirmed by employing molecular docking studies. The formulation of DMP involved the incorporation of IC with polyvinyl alcohol (PVA) and polyvinylpyrrolidone (PVP). The mechanical strength, ability to be inserted, and propensity to irritate Amphotericin B-Inclusion Complex-Dissolvable Microarray Patches (IC-DMP) were evaluated by laboratory experiments utilizing the porcine vaginal mucosal layer. Further investigations, such as Differential Scanning Calorimetry (DSC), were performed to assess the physicochemical characteristics of the IC. Results The solubility of the pure medication was greatly enhanced up to fourfold by the inclusion complex. The assessment of IC-DMP exhibited exceptional mechanical robustness and insertion abilities, with no indications of discomfort. Among the formulas tested in ex vivo vaginal kinetic experiments, Formula F3 had the most effective retention in the porcine vaginal mucosal layer. It had an AUC value of 208.02 ± 0.33 h.µg/cm3 and the highest Cmax value of 20.05 ± 0.06 µg/cm3. Therefore, Formula F3 was the most efficient formula in terms of vaginal drug delivery. Conclusion The integration of IC into the DMP system significantly enhances the solubility and bioavailability of AMB, facilitating its absorption in the circulatory system when applied intravaginally for vulvovaginal candidiasis treatment. These promising initial findings support further clinical evaluation of this novel drug delivery system. Graphical Abstract
- 12 December 2024
- Published by Springer Nature in DARU Journal of Pharmaceutical Sciences
- Vol. 33 (1) , 1-19
Development of amphotericin B inclusion complex formulation in dissolvable microarray patches for intravaginal delivery
Background Amphotericin B (AMB) is a drug used to treat vulvovaginal candidiasis (VVC), which is a fungal infection affecting the vagina and vulva. Nevertheless, the substance's limited capacity to dissolve in water leads to poor absorption when taken orally, hence diminishing its therapeutic efficacy. In order to address this limitation, β-cyclodextrin (βCD) was used to create AMB in the form of an inclusion complex. Objective This study aims to enhance the solubility and bioavailability of AMB by formulating it into an inclusion complex with βCD. Subsequently, we developed dissolvable microarray patches (DMP) as a novel drug delivery system, optimizing the formulation for improved retention, penetration, and controlled release of AMB. Methods The stability of the AMB-βCD inclusion complx (IC) structure has been confirmed by employing molecular docking studies. The formulation of DMP involved the incorporation of IC with polyvinyl alcohol (PVA) and polyvinylpyrrolidone (PVP). The mechanical strength, ability to be inserted, and propensity to irritate Amphotericin B-Inclusion Complex-Dissolvable Microarray Patches (IC-DMP) were evaluated by laboratory experiments utilizing the porcine vaginal mucosal layer. Further investigations, such as Differential Scanning Calorimetry (DSC), were performed to assess the physicochemical characteristics of the IC. Results The solubility of the pure medication was greatly enhanced up to fourfold by the inclusion complex. The assessment of IC-DMP exhibited exceptional mechanical robustness and insertion abilities, with no indications of discomfort. Among the formulas tested in ex vivo vaginal kinetic experiments, Formula F3 had the most effective retention in the porcine vaginal mucosal layer. It had an AUC value of 208.02 ± 0.33 h.µg/cm3 and the highest Cmax value of 20.05 ± 0.06 µg/cm3. Therefore, Formula F3 was the most efficient formula in terms of vaginal drug delivery. Conclusion The integration of IC into the DMP system significantly enhances the solubility and bioavailability of AMB, facilitating its absorption in the circulatory system when applied intravaginally for vulvovaginal candidiasis treatment. These promising initial findings support further clinical evaluation of this novel drug delivery system. Graphical Abstract
- Open Access
- 1 October 2024
- Published by Maad Rayan Publishing Company in Journal of Herbmed Pharmacology
- Vol. 13 (4) , 630-639
Computational investigation of Pluchea indica mechanism targeting peroxisome proliferator-activated receptor gamma
Introduction: Pluchea indica is known to have diverse pharmacological properties, including anti-inflammatory, antioxidant, antimicrobial, and anticancer activities. However, there is a pressing need to thoroughly investigate the molecular interactions between P. indica compounds and peroxisome proliferator-activated receptor gamma (PPARG). This study aimed to elucidate the molecular mechanisms behind P. indica and PPARG, and its potential implications for diabetes mellitus. Methods: The computational investigation employed Pharmacological Network pharmacology, homology modeling, deep learning docking, and molecular dynamics to explore the active compounds and targets within P. indica against the PPARG. Results: Three active compounds were identified namely pinoresinol, syringaresinol, and plucheoside A, all of which complied with the Lipinski rule of five. The deep learning-based pose scores were determined as follows: Pinoresinol 0.55, syringaresinol 0.32, and plucheoside A 0.44. Additionally, protein-protein interactions were observed with PPARG and associated with the PPAR signaling pathway. Molecular dynamics simulation analysis showed the stability of the three compounds over a 100 ns period. Free energy calculations using Molecular Mechanics-Generalized Born and Surface Area (MM-GBSA) yielded ΔG values of -44.39 kcal/mol, -51.83 kcal/mol, and -40.27 kcal/mol for pinoresinol, syringaresinol, and plucheoside A, respectively. Conclusion: Pluchea indica might be developed to treat various diseases, particularly those involving the PPARG signaling pathway. It suggests the possibility of being developed as a focused medication for diabetes.
- 1 October 2024
- Published by Maad Rayan Publishing Company in Journal of Herbmed Pharmacology
- Vol. 13 (4) , 630-639
Open AccessComputational investigation of Pluchea indica mechanism targeting peroxisome proliferator-activated receptor gamma
Introduction: Pluchea indica is known to have diverse pharmacological properties, including anti-inflammatory, antioxidant, antimicrobial, and anticancer activities. However, there is a pressing need to thoroughly investigate the molecular interactions between P. indica compounds and peroxisome proliferator-activated receptor gamma (PPARG). This study aimed to elucidate the molecular mechanisms behind P. indica and PPARG, and its potential implications for diabetes mellitus. Methods: The computational investigation employed Pharmacological Network pharmacology, homology modeling, deep learning docking, and molecular dynamics to explore the active compounds and targets within P. indica against the PPARG. Results: Three active compounds were identified namely pinoresinol, syringaresinol, and plucheoside A, all of which complied with the Lipinski rule of five. The deep learning-based pose scores were determined as follows: Pinoresinol 0.55, syringaresinol 0.32, and plucheoside A 0.44. Additionally, protein-protein interactions were observed with PPARG and associated with the PPAR signaling pathway. Molecular dynamics simulation analysis showed the stability of the three compounds over a 100 ns period. Free energy calculations using Molecular Mechanics-Generalized Born and Surface Area (MM-GBSA) yielded ΔG values of -44.39 kcal/mol, -51.83 kcal/mol, and -40.27 kcal/mol for pinoresinol, syringaresinol, and plucheoside A, respectively. Conclusion: Pluchea indica might be developed to treat various diseases, particularly those involving the PPARG signaling pathway. It suggests the possibility of being developed as a focused medication for diabetes.
- Open Access
- 7 September 2024
- Published by Innovare Academic Sciences Pvt Ltd in International Journal of Applied Pharmaceutics
- p. 90-98
METALLOPROTEIN PARAMETERS IN MOLECULAR DYNAMICS SIMULATION FOR AMBER, CHARMM, GROMACS, AND NAMD: A SYSTEMATIC REVIEW
Objective: The selection of appropriate metal parameters for molecular dynamics simulations is a significant challenge. Therefore, this review aims to provide in-depth insights valuable for the optimization of parameter selection in the context of chemical simulations. Methods: A total of 550 scientific articles were collected from pubmed and science direct databases from 2009 to 2024, resulting in the inclusion of 60 full studies for review. The selection process of preferred reporting items for systematic reviews and meta-analyses (PRISMA) was utilized, enabling the conduction of an initial screening of articles by use of the Rayyan web-based application. Results: This study found that the modeling and parameterization of metal proteins were categorized into bonded and non-bonded models. The Bonded Model incorporates MCPB, a Python-based software that facilitates parameter construction for over 80 metal ions and force fields in molecular dynamics simulations. The non-bonded model evaluates metals in proteins, such as zinc, nickel, magnesium, cobalt, iron, and cadmium by using AMBER force field and the Seminario method. The 12-6 lennard-Jones (LJ) non-bonded model is suitable for divalent, trivalent, and tetravalent metals, with Zinc parameters being compared for accuracy. Additionally, the force fields suitable for modeling unbound metal proteins include AMBER FF19SB, FF14SB, ff9X, CHARMM36, CHARMM22, CHARMM27, and CHARMM-Metal. Conclusion: This study found that the modeling and parameterization of metal proteins were categorized into bonded and non-bonded models. molecular dynamics (MD) simulations can be conducted using various methods, such as classical molecular dynamics, umbrella sampling, quantum mechanics-discrete molecular dynamics (QM/DMD), stochastic boundary molecular dynamics (SBMD), steered molecular dynamics (SMD), gaussian accelerated molecular dynamics (GaMD) and random acceleration molecular dynamics (RAMD).
- 7 September 2024
- Published by Innovare Academic Sciences Pvt Ltd in International Journal of Applied Pharmaceutics
- p. 90-98
Open AccessMETALLOPROTEIN PARAMETERS IN MOLECULAR DYNAMICS SIMULATION FOR AMBER, CHARMM, GROMACS, AND NAMD: A SYSTEMATIC REVIEW
Objective: The selection of appropriate metal parameters for molecular dynamics simulations is a significant challenge. Therefore, this review aims to provide in-depth insights valuable for the optimization of parameter selection in the context of chemical simulations. Methods: A total of 550 scientific articles were collected from pubmed and science direct databases from 2009 to 2024, resulting in the inclusion of 60 full studies for review. The selection process of preferred reporting items for systematic reviews and meta-analyses (PRISMA) was utilized, enabling the conduction of an initial screening of articles by use of the Rayyan web-based application. Results: This study found that the modeling and parameterization of metal proteins were categorized into bonded and non-bonded models. The Bonded Model incorporates MCPB, a Python-based software that facilitates parameter construction for over 80 metal ions and force fields in molecular dynamics simulations. The non-bonded model evaluates metals in proteins, such as zinc, nickel, magnesium, cobalt, iron, and cadmium by using AMBER force field and the Seminario method. The 12-6 lennard-Jones (LJ) non-bonded model is suitable for divalent, trivalent, and tetravalent metals, with Zinc parameters being compared for accuracy. Additionally, the force fields suitable for modeling unbound metal proteins include AMBER FF19SB, FF14SB, ff9X, CHARMM36, CHARMM22, CHARMM27, and CHARMM-Metal. Conclusion: This study found that the modeling and parameterization of metal proteins were categorized into bonded and non-bonded models. molecular dynamics (MD) simulations can be conducted using various methods, such as classical molecular dynamics, umbrella sampling, quantum mechanics-discrete molecular dynamics (QM/DMD), stochastic boundary molecular dynamics (SBMD), steered molecular dynamics (SMD), gaussian accelerated molecular dynamics (GaMD) and random acceleration molecular dynamics (RAMD).